Entyvio is the most prescribed biologic for UC and CD new start patients16‡. ‡ Based on an analysis of data in SHA database comparing patient counts on a quarterly basis from November 2019 to January 2021, with "new starts" defined as "bio-naïve" plus "switch" patients. "Bio-naïve" is defined as any patient with UC or CD who had no UC or ....